Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells.

Gargaro M, Vacca C, Massari S, Scalisi G, Manni G, Mondanelli G, Mazza EMC, Bicciato S, Pallotta MT, Orabona C, Belladonna ML, Volpi C, Bianchi R, Matino D, Iacono A, Panfili E, Proietti E, Iamandii IM, Cecchetti V, Puccetti P, Tabarrini O, Fallarino F, Grohmann U.

Front Immunol. 2019 Aug 20;10:1973. doi: 10.3389/fimmu.2019.01973. eCollection 2019.

2.

An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.

Bagadia P, Huang X, Liu TT, Durai V, Grajales-Reyes GE, Nitschké M, Modrusan Z, Granja JM, Satpathy AT, Briseño CG, Gargaro M, Iwata A, Kim S, Chang HY, Shaw AS, Murphy TL, Murphy KM.

Nat Immunol. 2019 Sep;20(9):1174-1185. doi: 10.1038/s41590-019-0449-3. Epub 2019 Aug 12.

PMID:
31406377
3.

Toll-like receptors as novel therapeutic targets for herpes simplex virus infection.

Jahanban-Esfahlan R, Seidi K, Majidinia M, Karimian A, Yousefi B, Nabavi SM, Astani A, Berindan-Neagoe I, Gulei D, Fallarino F, Gargaro M, Manni G, Pirro M, Xu S, Sadeghi M, Nabavi SF, Shirooie S.

Rev Med Virol. 2019 Jul;29(4):e2048. doi: 10.1002/rmv.2048. Epub 2019 Jul 2. Review.

PMID:
31265195
4.

IL-35Ig-expressing dendritic cells induce tolerance via Arginase 1.

Panfili E, Mondanelli G, Orabona C, Bianchi R, Gargaro M, Fallarino F, Puccetti P, Grohmann U, Volpi C, Belladonna ML.

J Cell Mol Med. 2019 May;23(5):3757-3761. doi: 10.1111/jcmm.14215. Epub 2019 Feb 22.

5.

Onion (Allium cepa L.) Skin: A Rich Resource of Biomolecules for the Sustainable Production of Colored Biofunctional Textiles.

Pucciarini L, Ianni F, Petesse V, Pellati F, Brighenti V, Volpi C, Gargaro M, Natalini B, Clementi C, Sardella R.

Molecules. 2019 Feb 11;24(3). pii: E634. doi: 10.3390/molecules24030634.

6.

WDFY4 is required for cross-presentation in response to viral and tumor antigens.

Theisen DJ, Davidson JT 4th, Briseño CG, Gargaro M, Lauron EJ, Wang Q, Desai P, Durai V, Bagadia P, Brickner JR, Beatty WL, Virgin HW, Gillanders WE, Mosammaparast N, Diamond MS, Sibley LD, Yokoyama W, Schreiber RD, Murphy TL, Murphy KM.

Science. 2018 Nov 9;362(6415):694-699. doi: 10.1126/science.aat5030.

7.

Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1.

Albini E, Coletti A, Greco F, Pallotta MT, Mondanelli G, Gargaro M, Belladonna ML, Volpi C, Bianchi R, Grohmann U, Macchiarulo A, Orabona C.

Biochem Pharmacol. 2018 Dec;158:286-297. doi: 10.1016/j.bcp.2018.10.033. Epub 2018 Nov 1.

8.

S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cells.

Romani R, Manni G, Donati C, Pirisinu I, Bernacchioni C, Gargaro M, Pirro M, Calvitti M, Bagaglia F, Sahebkar A, Clerici G, Matino D, Pomili G, Di Renzo GC, Talesa VN, Puccetti P, Fallarino F.

Eur J Pharmacol. 2018 Aug 15;833:173-182. doi: 10.1016/j.ejphar.2018.06.005. Epub 2018 Jun 7.

9.

IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases.

Teymouri M, Pirro M, Fallarino F, Gargaro M, Sahebkar A.

Int J Cancer. 2018 Nov 1;143(9):2105-2115. doi: 10.1002/ijc.31382. Epub 2018 Mar 31. Review.

PMID:
29574719
10.

Altered compensatory cytokine signaling underlies the discrepancy between Flt3-/- and Flt3l-/- mice.

Durai V, Bagadia P, Briseño CG, Theisen DJ, Iwata A, Davidson JT 4th, Gargaro M, Fremont DH, Murphy TL, Murphy KM.

J Exp Med. 2018 May 7;215(5):1417-1435. doi: 10.1084/jem.20171784. Epub 2018 Mar 23.

11.

Targeting metabotropic glutamate receptors for the treatment of neuroinflammation.

Fazio F, Ulivieri M, Volpi C, Gargaro M, Fallarino F.

Curr Opin Pharmacol. 2018 Feb;38:16-23. doi: 10.1016/j.coph.2018.01.010. Epub 2018 Feb 19. Review.

PMID:
29471184
12.

Binding Mode and Structure-Activity Relationships of ITE as an Aryl Hydrocarbon Receptor (AhR) Agonist.

Dolciami D, Gargaro M, Cerra B, Scalisi G, Bagnoli L, Servillo G, Fazia MAD, Puccetti P, Quintana FJ, Fallarino F, Macchiarulo A.

ChemMedChem. 2018 Feb 6;13(3):270-279. doi: 10.1002/cmdc.201700669. Epub 2018 Jan 23.

PMID:
29266750
13.

Interaction of 7-Alkoxycoumarins with the Aryl Hydrocarbon Receptor.

Gargaro M, Epifano F, Fiorito S, Taddeo VA, Genovese S, Pirro M, Turco A, Puccetti P, Schmidt-Weber CB, Fallarino F.

J Nat Prod. 2017 Jun 23;80(6):1939-1943. doi: 10.1021/acs.jnatprod.7b00173. Epub 2017 May 19.

PMID:
28525281
14.

CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.

Crooks J, Gargaro M, Vacca C, Volpi C, Pirro M, Scalisi G, Turco A, Romani R, Matino D, Rostami A, Puccetti P, Gran B, Fallarino F.

Mediators Inflamm. 2017;2017:1380615. doi: 10.1155/2017/1380615. Epub 2017 Mar 5.

15.

Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms.

Briseño CG, Gargaro M, Durai V, Davidson JT, Theisen DJ, Anderson DA 3rd, Novack DV, Murphy TL, Murphy KM.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3957-3962. doi: 10.1073/pnas.1619863114. Epub 2017 Mar 27.

16.

Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1.

Albini E, Rosini V, Gargaro M, Mondanelli G, Belladonna ML, Pallotta MT, Volpi C, Fallarino F, Macchiarulo A, Antognelli C, Bianchi R, Vacca C, Puccetti P, Grohmann U, Orabona C.

J Cell Mol Med. 2017 Jan;21(1):165-176. doi: 10.1111/jcmm.12954. Epub 2016 Sep 30.

17.

Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.

Fallarino F, Gargaro M, Mondanell G, Downer EJ, Hossain MJ, Gran B.

Methods Mol Biol. 2016;1390:383-411. doi: 10.1007/978-1-4939-3335-8_23.

PMID:
26803641
18.

Aryl Hydrocarbon Receptor-Dependent Pathways in Immune Regulation.

Gargaro M, Pirro M, Romani R, Zelante T, Fallarino F.

Am J Transplant. 2016 Aug;16(8):2270-6. doi: 10.1111/ajt.13716. Epub 2016 Mar 10. Review.

19.

Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.

Volpi C, Mondanelli G, Pallotta MT, Vacca C, Iacono A, Gargaro M, Albini E, Bianchi R, Belladonna ML, Celanire S, Mordant C, Heroux M, Royer-Urios I, Schneider M, Vitte PA, Cacquevel M, Galibert L, Poli SM, Solari A, Bicciato S, Calvitti M, Antognelli C, Puccetti P, Orabona C, Fallarino F, Grohmann U.

Neuropharmacology. 2016 Mar;102:59-71. doi: 10.1016/j.neuropharm.2015.10.036. Epub 2015 Oct 30.

20.

IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.

Matino D, Gargaro M, Santagostino E, Di Minno MN, Castaman G, Morfini M, Rocino A, Mancuso ME, Di Minno G, Coppola A, Talesa VN, Volpi C, Vacca C, Orabona C, Iannitti R, Mazzucconi MG, Santoro C, Tosti A, Chiappalupi S, Sorci G, Tagariello G, Belvini D, Radossi P, Landolfi R, Fuchs D, Boon L, Pirro M, Marchesini E, Grohmann U, Puccetti P, Iorio A, Fallarino F.

J Clin Invest. 2015 Oct 1;125(10):3766-81. doi: 10.1172/JCI81859. Epub 2015 Aug 31.

21.

Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.

Romani R, Pirisinu I, Calvitti M, Pallotta MT, Gargaro M, Bistoni G, Vacca C, Di Michele A, Orabona C, Rosati J, Pirro M, Giovagnoli S, Matino D, Prontera P, Rosi G, Grohmann U, Talesa VN, Donti E, Puccetti P, Fallarino F.

J Cell Mol Med. 2015 Jul;19(7):1593-605. doi: 10.1111/jcmm.12534. Epub 2015 Mar 17.

22.

The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors.

Sabatini S, Manfroni G, Barreca ML, Bauer SM, Gargaro M, Cannalire R, Astolfi A, Brea J, Vacca C, Pirro M, Massari S, Tabarrini O, Loza MI, Fallarino F, Laufer SA, Cecchetti V.

Chem Biol Drug Des. 2015 Oct;86(4):531-45. doi: 10.1111/cbdd.12516. Epub 2015 Feb 19.

PMID:
25589097
23.

Tryptophan Feeding of the IDO1-AhR Axis in Host-Microbial Symbiosis.

Zelante T, Iannitti RG, Fallarino F, Gargaro M, De Luca A, Moretti S, Bartoli A, Romani L.

Front Immunol. 2014 Dec 15;5:640. doi: 10.3389/fimmu.2014.00640. eCollection 2014. Review. No abstract available.

24.

Ligand binding and functional selectivity of L-tryptophan metabolites at the mouse aryl hydrocarbon receptor (mAhR).

Nuti R, Gargaro M, Matino D, Dolciami D, Grohmann U, Puccetti P, Fallarino F, Macchiarulo A.

J Chem Inf Model. 2014 Dec 22;54(12):3373-83. doi: 10.1021/ci5005459. Epub 2014 Nov 21.

PMID:
25402742
25.

LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism.

Fallarino F, Pallotta MT, Matino D, Gargaro M, Orabona C, Vacca C, Mondanelli G, Allegrucci M, Boon L, Romani R, Talesa VN, Puccetti P, Grohmann U.

Immunobiology. 2015 Feb;220(2):315-21. doi: 10.1016/j.imbio.2014.09.017. Epub 2014 Sep 28.

PMID:
25278421
26.

Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes.

Pallotta MT, Orabona C, Bianchi R, Vacca C, Fallarino F, Belladonna ML, Volpi C, Mondanelli G, Gargaro M, Allegrucci M, Talesa VN, Puccetti P, Grohmann U.

J Cell Mol Med. 2014 Oct;18(10):2082-91. doi: 10.1111/jcmm.12360. Epub 2014 Sep 12.

27.

Aryl hydrocarbon receptor control of a disease tolerance defence pathway.

Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz TV, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, DuHadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F, Puccetti P.

Nature. 2014 Jul 10;511(7508):184-90. doi: 10.1038/nature13323.

28.

Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.

Fazio F, Zappulla C, Notartomaso S, Busceti C, Bessede A, Scarselli P, Vacca C, Gargaro M, Volpi C, Allegrucci M, Lionetto L, Simmaco M, Belladonna ML, Nicoletti F, Fallarino F.

Neuropharmacology. 2014 Jun;81:237-43. doi: 10.1016/j.neuropharm.2014.02.011. Epub 2014 Feb 21.

PMID:
24565643

Supplemental Content

Loading ...
Support Center